A 'Novel' Anti-inflammatory
"We discuss the concept of using low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain conditions that are suspected to be associated with inflammatory processes."
Low dose Naltrexone is one of the more intriguing treatment options to emerge Read more [...]
"We ...feel this is a real game changer" Dr. Pridgen
With 90% of the data from their big Fibromyalgia antiviral study in, Dr. William "Skip" Pridgen reported in the Tuscaloosa News that the results were 'very positive'. Pridgen enthusiastically stated, "We feel we are on the right track and feel Read more [...]
Depression is common in fibromyalgia. In fact, with studies suggesting levels of 'current depression range from 22-44% and lifetime rates of depression from 60-86%,depression in FM may be very common. This isn't surprising: the presence of pain in any disorder increases the risk of depression Read more [...]
Chimerix, the manufacturer of the herpesvirus drug, brincidofovir (formerly known as CMX001), recently went public and the guess is that they're very confident about getting FDA approval. On your alternative treatments page you note brincidofovir appears to be 100x's more powerful that Read more [...]
Fibromyalgia, not chronic fatigue syndrome, is going be the recipient of the first large, multi-center antiviral treatment trial. In an entirely new approach to FM, Dr. Skip Pridgen is using a novel two-drug approach, to smother the herpesviruses he believes are causing the disorder (and ME/CFS Read more [...]
The F.D.A. recommendation is likely to have a significant impact on the availability of the drugs. New York Times
Last week FDA's ruling reclassifying narcotic pain relievers such as Vicodin and Lortab which contain hydrocodone combined with acetaminophen as schedule II drugs will make them more difficult Read more [...]
A Blockbuster Drug
Lyrica truly merits the description ‘blockbuster drug’. FDA approved for seizures, neuropathic pain, fibromyalgia (2007), and generalized anxiety disorder (Europe), Lyrica (pregabalin) sales hit their peak in the last quarter in the US, bringing in over $550 million for Pfizer.
Lyrica’s Read more [...]
"The present case highlights the marked improvement of FM symptoms in a patient who has been resistant to a wide variety of treatments for over seven years.“ Kararizou et. al. 2013
The Big Three (Lyrica, Cymbalta, Savella) Ghetto in Fibromyalgia
Don’t get stuck in a rut when your doctor only Read more [...]